Skip to main content
OpenTrials

Clinical trial condition

Metastatic Head and Neck Squamous Cell Carcinoma

Explore clinical trials studying Metastatic Head and Neck Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

29 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Head and Neck Squamous Cell Carcinoma trial results

Active, not recruiting

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

NCT05172258

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
View all 20 locations
View Trial Details
Active, not recruiting

Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC

NCT03813836

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations
  • Aberdeen Royal Infirmary (NHS Grampian) Aberdeen, United Kingdom
  • Bristol Haematology and Oncology Centre (University Hospital Bristol NHS Foundation Trust) Bristol, United Kingdom
  • Western General Hospital (NHS Lothian) Edinburgh, United Kingdom
  • East Suffolk and North Essex NHS Foundation Trust Ipswich, United Kingdom
View Trial Details

Related conditions